Belgium : Recommended vaccinations
  General recommendation
  Recommendation for specific groups only
  Catch-up (e.g. if previous doses missed)
 
Vaccination not funded by the National Health system
 
Mandatory vaccination
BirthMonthsYears
234612155-67-81012-1314151618
RSV
RSV1
Coronavirus disease (COVID-19)
COVID-192
rotavirus infection
ROTA
ROTA
ROTA3
diphtheria
D
D
D
D
D
d
d4
tetanus
TT
TT
TT
TT
TT
TT
TT4
pertussis
acP
acP
acP
acP
acP
acp
acp4
poliomyelitis
IPV
IPV
IPV
IPV
IPV
IPV5
Haemophilus influenzae type b infection
Hib
Hib
Hib
Hib
hepatitis B
HepB6
HepB
HepB
HepB
HepB
HepB
HepB7
pneumococcal disease
PCV13 or PCV208
PCV13 or PCV208
PCV13 or PCV208
PCV20
meningococcal disease
MCV4
MCV49
measles
MEAS
MEAS10
mumps
MUMPS
MUMPS10
rubella
RUBE
RUBE10
varicella
VAR11
human papillomavirus infection
HPV9 (F/M)12
HPV9 (F/M)
influenza
IIV413
hepatitis A
HepA14

Version:


Footnotes:

  1. The vaccine is recommended and partially reimbursed for pregnant women between gestational weeks 28 and 36 as part of a combined strategy with monoclonal antibodies. It is typically administered as a single-dose program during the autumn and winter seasons.
  2. Recommended to persons <65y of age who are care workers or belong to medical risk groups; Recommended to persons aged >= 65 years. More info, see https://www.hgr-css.be/fr/avis/9880/strategie-belge-de-vaccination-contre-le-covid-19-saison-2025-2026
  3. 3rd dose only for pentavalent rotavirus vaccines
  4. One dose of dTTaP every 10 years for adults after receiving the childhood immunisation schedule. Vaccination of expectant mothers during every pregnancy with a pertussis-containing vaccine in week 24 to week 32 of pregnancy. dTTaP boosters are funded for all pregnant women nationally. However, these booster doses are only offered for free in other adults in Flanders region.
  5. A supplementary polio revaccination (to be paid out of pocket) is mandatory (or strongly recommended according to the countries) for travellers (of all ages) staying longer than 4 weeks in countries infected by wild poliovirus or circulating vaccine derived poliovirus (cVDPV) with potential risk of international spread. These recommendations follow the statement of the Emergency Committee under the International Health Regulations (2005) (IHR) regarding the international spread of poliovirus, and they are regularly adjusted to this statement. The revaccination consists of 1 dose of the vaccine administered between 4 weeks and 12 months before the traveler leaves the concerned countries. For detailed information: see: https://www.health.belgium.be/sites/default/files/uploads/fields/fpshealth_theme_file/css_9208b_polio_adultes.pdf and Institute of Tropical Medicine: Travel Medicine - Tropical and Import Pathology: http://www.itg.be/E/Article/additional-polio-vaccination
  6. Babies born to a mother infected with hepatitis B will be offered a dose at birth simultaneously with HB immunoglobulin
  7. Not-reimbursed vaccination of specific risk groups (see detailed information https://www.health.belgium.be/fr/avis-8816-vaccination-de-ladulte-contre-lhepatite-b-fiche)
  8. PCV20 is recommended but not implemented in the free routine vaccination programs. For infants, free vaccination with PCV13 (2-4-12m) is offered by the federated entities
  9. Adolescent dose recommended but not implemented in free vaccination programs
  10. Regarding implementation, MMR2 in the free routine vaccination program in Flanders has been moved to 24 months
  11. For healthy susceptible close household contacts of immunocompromised patients and healthcare workers. For adolescents and adults with no antecedents of varicella (after serological testing). Two doses of varicella vaccine, four to eight weeks apart.
  12. In the French-speaking community, the target age group is 13-14 years old.
  13. For HCWs (paid by employer), pregnant women and people with comorbidities (partially reimbursed).
  14. For specific risk groups (see detailed information https://www.health.belgium.be/fr/avis-8816-vaccination-de-ladulte-contre-lhepatite-b-fiche )


More information available at:
http://www.vaccination-info.be/ https://www.hgr-css.be/fr/avis



--------------------------------------------------------------------------------

The Belgian Superior Health Council (SHC) gives a scientific recommendation on the immunization schedule as presented in this summary table.
https://www.health.belgium.be/fr/vaccination
The community governments are responsible for the implementation, organization and promotion of the recommended vaccination programs, and are in charge of purchasing most of the traditional infant and adolescent vaccines.
It should be noted that although Rotavirus vaccination is recommended, it is not implemented in the vaccination programs of the community governments.

HPV vaccination is implemented in the vaccination programme of the community governments, in Flanders since September 2010 and in Wallonia-Brussels since September 2011. This programme is directed to one birth cohort of girls.

Pertussis vaccination is proposed for free - in Flanders to all pregnant women and to other adults (at the time of the dTT booster) since 1 July 2014 - in Wallonia to all pregnant women since 1 January 2015.

Specific information on the vaccination programme for Flanders: http://www.zorg-en-gezondheid.be/basisvaccinatieschema/
Specific information on the vaccination programme for Wallonia-Brussels: https://www.e-vax.be/welkom.do and http://www.vaccination-info.be/

Specific information on catch-up vaccination: https://www.health.belgium.be/fr/vaccination#Autres%20fiches%20de%20vaccination

--------------------------------------------------------------------------------

Specific comments re. specific vaccination

2019 - MMR vaccination. Age of second dose advanced to 7-9 years (11-13 years before)

2019 - Meningococcal vaccination. In the general vaccination schedule, the MenC vaccination at 15 months of age is replaced by a dose of a conjugated meningococcal serogroup ACWY vaccine and an additional dose a conjugated meningococcal serogroup ACWY vaccine is scheduled at the age of 14-16 at the time of the dTap vaccine in adolescents.
By March 2021, this recommendation was not yet integrated in the current vaccination programs in Flanders and in Wallonia/Brussels.


--------------------------------------------------------------------------------
Date of last update: 4 February 2026
--------------------------------------------------------------------------------